Subcutaneous Epcoritamab + R-Dhax/C in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma Eligible for Autologous Stem Cell Transplant: Updated Phase 1/2 Results
暂无分享,去创建一个
S. de Vos | P. Abrisqueta | T. Phillips | F. Offner | L. Falchi | M. Nijland | Jun Wu | Liwei Wang | R. Córdoba | I. Bykhovski | A. Rana